Casey Theriot
Titolo
Citata da
Citata da
Anno
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
CM Theriot, MJ Koenigsknecht, PE Carlson Jr, GE Hatton, AM Nelson, ...
Nature communications 5, 3114, 2014
592*2014
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
C Ma, M Han, B Heinrich, Q Fu, Q Zhang, M Sandhu, D Agdashian, ...
Science 360 (6391), 2018
3052018
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection
AE Reeves, CM Theriot, IL Bergin, GB Huffnagle, PD Schloss, VB Young
Gut microbes 2 (3), 145-158, 2011
2172011
Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine
CM Theriot, AA Bowman, VB Young
MSphere 1 (1), e00045-15, 2016
188*2016
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
CM Theriot, VB Young
Annual review of microbiology 69, 445-461, 2015
1792015
Hydrolysis of organophosphorus compounds by microbial enzymes
CM Theriot, AM Grunden
Applied Microbiology and Biotechnology 89 (1), 35-43, 2011
1412011
Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains
CM Theriot, CC Koumpouras, PE Carlson, II Bergin, DM Aronoff, ...
Gut microbes 2 (6), 326-334, 2011
1242011
Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract
MJ Koenigsknecht, CM Theriot, IL Bergin, CA Schumacher, PD Schloss, ...
Infection and immunity 83 (3), 934-941, 2015
1052015
Metabolic model-based integration of microbiome taxonomic and metabolomic profiles elucidates mechanistic links between ecological and metabolic variation
C Noecker, A Eng, S Srinivasan, CM Theriot, VB Young, JK Jansson, ...
MSystems 1 (1), 2016
922016
Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids
R Thanissery, JA Winston, CM Theriot
Anaerobe 45, 86-100, 2017
782017
Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection
CM Theriot, VB Young
Gut Microbes 5 (1), 86-95, 2014
752014
High-throughput amplicon sequencing of the full-length 16S rRNA gene with single-nucleotide resolution
BJ Callahan, J Wong, C Heiner, S Oh, CM Theriot, AS Gulati, SK McGill, ...
Nucleic acids research 47 (18), e103-e103, 2019
702019
Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract
JA Winston, CM Theriot
Anaerobe 41, 44-50, 2016
692016
Fecal microbiota transplantation eliminates Clostridium difficile in a murine model of relapsing disease
AM Seekatz, CM Theriot, CT Molloy, KL Wozniak, IL Bergin, VB Young
Infection and immunity 83 (10), 3838-3846, 2015
692015
Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection
CM Bassis, CM Theriot, VB Young
Antimicrobial agents and chemotherapy 58 (5), 2767-2774, 2014
662014
Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection
AM Seekatz, CM Theriot, K Rao, YM Chang, AE Freeman, JY Kao, ...
Anaerobe 53, 64-73, 2018
622018
The complete Campylobacter jejuni transcriptome during colonization of a natural host determined by RNAseq
ME Taveirne, CM Theriot, J Livny, VJ DiRita
PloS one 8 (8), e73586, 2013
602013
Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract
MH Foley, S O’Flaherty, R Barrangou, CM Theriot
PLoS Pathogens 15 (3), e1007581, 2019
402019
Shifts in the gut metabolome and Clostridium difficile transcriptome throughout colonization and infection in a mouse model
JR Fletcher, S Erwin, C Lanzas, CM Theriot
mSphere 3 (2), 2018
382018
Improving the catalytic activity of hyperthermophilic Pyrococcus prolidases for detoxification of organophosphorus nerve agents over a broad range of temperatures
CM Theriot, X Du, SR Tove, AM Grunden
Applied microbiology and biotechnology 87 (5), 1715-1726, 2010
282010
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20